ERYTHROMYCIN STEARATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Erythromycin Stearate, and what generic alternatives are available?
Erythromycin Stearate is a drug marketed by Ani Pharms, Lederle, Norvium Bioscience, Purepac Pharm, and Watson Labs. and is included in seven NDAs.
The generic ingredient in ERYTHROMYCIN STEARATE is erythromycin stearate. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin stearate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERYTHROMYCIN STEARATE?
- What are the global sales for ERYTHROMYCIN STEARATE?
- What is Average Wholesale Price for ERYTHROMYCIN STEARATE?
Summary for ERYTHROMYCIN STEARATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Clinical Trials: | 1 |
| Patent Applications: | 7,106 |
| Drug Prices: | Drug price information for ERYTHROMYCIN STEARATE |
| DailyMed Link: | ERYTHROMYCIN STEARATE at DailyMed |
Recent Clinical Trials for ERYTHROMYCIN STEARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chr Hansen A/S | N/A |
| Chr Hansen | N/A |
| Ryerson University | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN STEARATE
US Patents and Regulatory Information for ERYTHROMYCIN STEARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061461-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061505-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 063179-001 | May 15, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061505-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061591-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 061461-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Lederle | ERYTHROMYCIN STEARATE | erythromycin stearate | TABLET;ORAL | 062089-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
